The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag.Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost -- for now. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week.
The Department of Veterans Affairs, the Department of Defense and Indian Health Service will still be able to access Paxlovid the government has on hand. The government will also get 1 million treatment courses to keep in its stockpile.Suppliers to pharmacies, doctor’s offices and hospitals can begin ordering the treatments from the drug companies starting next week.“Pfizer is committed to a smooth commercial transition and is working collaboratively with the U.S.
Colombia Últimas Noticias, Colombia Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
COVID-19 treatments to enter the market with a hefty price tagThe COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag. Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost -- for now.
Leer más »
COVID-19 treatments to enter the market with a hefty price tagThe COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag
Leer más »
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Leer más »
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Leer más »
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Leer más »
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Leer más »